medigraphic.com
ISSN 0185-6014 (Print)
Órgano oficial de difusión de la Federación Mexicana de Patología Clínica, AC y de la Asociación Latinoamericana de Patología Clínica/Medicina de Laboratorio

2019, Number 2

<< Back Next >>

Rev Mex Patol Clin Med Lab 2019; 66 (2)

Liver disease and clinical laboratory

Barba EJR

Language: Spanish
References: 29
Page: 81-99
PDF size: 379.01 Kb.


ABSTRACT

At present, liver disease is not considered a serious public health problem, firstly, because the real prevalence of some entities such as carriers of hepatitis B and C is not known, and secondly because most diseases of this organ are chronic, and like any disease of this type, they manifest themselves when the condition is very advanced or the damage is irreversible, as occurs in non-alcoholic fatty liver. On the other hand, the participation of the laboratory is vital, since the profile of hepatic chemistry (badly called liver function test), are included with great frequency in routine examinations in asymptomatic patients as symptomatic, so it is of vital importance that the results are correctly evaluated.


REFERENCES

  1. Méndez-Sánchez N, Uribe M. Hepatología. Conceptos básicos y clínicos. Editorial McGraw-Hill/Interamericana Editores, S.A. de C.V; 2016.

  2. Soto-Estrada G, Moreno-Altamirano L, Pahua-Díaz D. Panorama epidemiológico de México, principales causas de morbilidad y mortalidad. Rev Fac Med (Méx.). 2016; 59 (6): 8-22.

  3. González-Jiménez D, Santos-Rodríguez PM. Hipertransaminasemia en pediatría. Bol Pediatr. 2013; 53: 137-145.

  4. Cequera A, García de León-Méndez MC. Biomarcadores para fibrosis hepática, avances, ventajas y desventajas. Rev Gastroenterol Méx. 2014; 79 (3): 187-199.

  5. Fernández-Daza E, Fernández JE, Moreno-Mejía I, Moreno-Mejía M. Aproximación al diagnóstico de enfermedades hepáticas por el laboratorio clínico. Medicina & Laboratorio. 2008; 14 (11-12): 533-546.

  6. del Valle-Díaz S, Piñera-Martínez M, Medina-González N, Sánchez-Vega J. Colestasis: un enfoque actualizado. MEDISAN. 2017; 21 (7): 876-900.

  7. McGill MR. The past and present of serum aminotransferases and the future of liver injury biomarkers. EXCLI J. 2016; 15: 817-828.

  8. Söderberg C, Stål P, Askling J, Glaumann H, Lindberg G, Marmur J et al. Decreased survival of subjects with elevated liver function tests during a 28-year follow-up. Hepatology. 2010; 51 (2): 595-602.

  9. Moreno-Borque A, González-Moreno L, Mendoza-Jiménez J, García-Buey L, Moreno-Otero R. Utilidad de los parámetros analíticos en el diagnóstico de las enfermedades hepáticas. An Med Interna. 2007; 2 (1): 38-46.

  10. Kwo PY, Cohen SM, Lim JK. ACG Clinical Guideline: evaluation of abnormal liver chemistries. Am J Gastroenterol. 2017; 112 (1): 18-35.

  11. Thapa BR, Walia A. Liver function tests and their interpretation. Indian J Pediatr. 2007; 74 (7): 663-671.

  12. Malinowski M, Jara M, Lüttgert K, Orr J, Lock JF, Schott E et al. Enzymatic liver function capacity correlates with disease severity of patients with liver cirrhosis: a study with the LiMAx test. Dig Dis Sci. 2014; 59 (12): 2983-2991.

  13. www.aegastro.es/sites/default/files/archivos/ayudaspracticas/48_Datos_laboratorio_Pruebas_hepaticas_alteradas.

  14. Hall P, Cash J. What is the real function of the liver ‘function’ tests? Ulster Med J. 2012; 81 (1): 30-36.

  15. Lui F. Laboratory tests in liver failure. JAICM. 2017; 19 (1): 1-3.

  16. The National Academy of Clinical Biochemistry. Guías del laboratorio para screening, diagnóstico y monitoreo de la lesión hepática. Acta Bioquím Clín Latinoam 2005; 39(3): 359-376.

  17. Limdi JK, Hyde GM. Evaluation of abnormal liver function tests. Postgrad Med J. 2003; 79 (932): 307-312.

  18. Gowda S, Desai PB, Hull VV, Math AA, Vernekar SN, Kulkarni SS. A review on laboratory liver function tests. Pan Afr Med J. 2009; 3: 17.

  19. Tapper EB, Saini SD, Sengupta N. Extensive testing or focused testing of patients with elevated liver enzymes. J Hepatol. 2017; 66 (2): 313-319.

  20. Ahmed Z, Ahmed U, Walayat S, Ren J, Martin DK, Moole H et al. Liver function tests in identifying patients with liver disease. Clin Exp Gastroenterol. 2018; 11: 301-307.

  21. Hammer GD, McPhee SJ. Fisiopatología de la enfermedad. Una introducción a la medicina clínica. 7ª edición. McGraw-Hill LANGE; 2015.

  22. Astegiano M, Sapone N, Demarchi B, Rossetti S, Bonardi R, Rizzetto M. Laboratory evaluation of the patient with liver disease. Eur Rev Med Pharmacol Sci. 2004; 8 (1): 3-9.

  23. Krier M, Ahmed A. The asymptomatic outpatient with abnormal liver function tests. Clinics in Liver Disease. 2009; 13 (2): 167-177.

  24. Mahl TC. Approach to the patient with abnormal liver tests. Lippincotts Prim Care Pract. 1998; 2 (4): 379-389.

  25. Rincón-Rodríguez D, Pérez-Carazob L, Klímováb K. Interpretación diagnóstica y pronóstica de las pruebas de función hepática. Medicine-Programa de Formación Médica Continuada Acreditado. 2012; 11 (12): 733-739.

  26. Jalan R, Hayes PC. Review article: quantitative tests of liver function. Aliment Pharmacol Ther. 1995; 9 (3): 263-270.

  27. Ilan Y. Review article: the assessment of liver function using breath tests. Aliment Pharmacol Ther. 2007; 26 (10): 1293-1302.

  28. O’Brien CB. The hospitalized patient with abnormal liver function tests. Clin Liver Dis. 2009; 13 (2): 179-192.

  29. Greene CH, Snell AM, Walters W. Diseases of the liver. I a survey of tests for hepatic function. Arch Intern Med. 1925; 36 (2): 248-272.




2020     |     www.medigraphic.com